EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Transposable elements as drivers of dedifferentiation: Connections between enhancers in embryonic stem cells, placenta, and cancer

Konsta Karttunen iD, Divyesh Patel iD, Biswajyoti Sahu iD

BioEssays · 2024-10 · 46 (10)

DOI: 10.1002/bies.202400059 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioEssays, online erschienen am 29.07.2024. Verfasst von Konsta Karttunen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Applied Tumor Genomics Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: DNA Transposable Elements, Placenta, Embryonic Stem Cells, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland, iCAN Digital Precision Cancer Medicine Flagship, Cancer Foundation Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transposable elements (TEs) have emerged as important factors in establishing the cell type‐specific gene regulatory networks and evolutionary novelty of embryonic and placental development. Recently, studies on the role of TEs and their dysregulation in cancers have shed light on the transcriptional, transpositional, and regulatory activity of TEs, revealing that the activation of developmental transcriptional programs by TEs may have a role in the dedifferentiation of cancer cells to the progenitor‐like cell states. This essay reviews the recent evidence of the cis ‐regulatory TEs (henceforth crTE) in normal development and malignancy as well as the key transcription factors and regulatory pathways that are implicated in both cell states, and presents existing gaps remaining to be studied, limitations of current technologies, and therapeutic possibilities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Transposable ElementsPlacentaEmbryonic Stem CellsNeoplasmsHumansAnimalsFemalePregnancyEnhancer Elements, GeneticCell DedifferentiationGene Regulatory NetworksGene Expression Regulation, Developmental

Stichwörter der Autor:innen

cancerdedifferentiationdevelopmentepigeneticsgenomicsimmunotherapytransposable elements

Substanzen

DNA Transposable Elements

Autor:innen und Institutionen

  • Applied Tumor Genomics Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.
  • Centre for Molecular Medicine Norway, University of Oslo, Oslo, Norway.
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

ORCID-Profile: Konsta Karttunen, Divyesh Patel, Biswajyoti Sahu

Förderung

  • Academy of Finland
  • iCAN Digital Precision Cancer Medicine Flagship
  • Cancer Foundation Finland
  • Sigrid Jusélius Foundation
  • Jane and Aatos Erkko Foundation
  • Centre for Molecular Medicine Norway, University of Oslo
  • Syöpäsäätiö
  • Sigrid Juséliuksen Säätiö

Zitieren

APA

Karttunen, K., Patel, D., & Sahu, B. (2024). Transposable elements as drivers of dedifferentiation: Connections between enhancers in embryonic stem cells, placenta, and cancer. BioEssays, 46(10). https://doi.org/10.1002/bies.202400059

Vancouver

Karttunen K, Patel D, Sahu B. Transposable elements as drivers of dedifferentiation: Connections between enhancers in embryonic stem cells, placenta, and cancer. BioEssays. 2024;46(10). doi:10.1002/bies.202400059

BibTeX
@article{Karttunen2024,
  author = {Karttunen, Konsta and Patel, Divyesh and Sahu, Biswajyoti},
  title = {Transposable elements as drivers of dedifferentiation: Connections between enhancers in embryonic stem cells, placenta, and cancer},
  journal = {BioEssays},
  year = {2024},
  volume = {46},
  number = {10},
  doi = {10.1002/bies.202400059}
}
Kostenlos starten →